Finance

Beta
Lists
AURX:OTCMKTS
Nuo Therapeutics Inc
$1.04
0.00%
(0.00) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURX...
Open
$1.04
High
$1.04
Low
$1.04
Mkt. cap
50.35M
Avg. vol.
4.11K
Volume
500.00
52-wk high
$3.23
52-wk low
$0.84
EPS
-$0.05
Beta
-4.67
Shares outstanding
48.41M
No. of employees
10
Open
$1.04
High
$1.04
Low
$1.04
Mkt. cap
50.35M
Avg. vol.
4.11K
Volume
500.00
52-wk high
$3.23
52-wk low
$0.84
EPS
-$0.05
Beta
-4.67
Shares outstanding
48.41M
No. of employees
10
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to AURX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for AURX in the last 3 months.
Highest
Current $1.04
$3.00 (+188.46%)
Average
$3.00 (+188.46%)
Lowest
$3.00 (+188.46%)
News stories
From sources across the web
About Nuo Therapeutics Inc
CEO-
Employees10
Founded1998
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitenuot.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
700.20K
1.03M
1.10M
1.30M
Cost of goods sold
159.35K
406.72K
408.46K
452.39K
Cost of revenue
159.35K
406.72K
408.46K
452.39K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.19M
1.17M
1.27M
1.30M
Operating expense
1.19M
1.17M
1.27M
1.30M
Total operating expenses
1.35M
1.57M
1.68M
1.75M
Operating income
-652.02K
-540.14K
-579.34K
-446.47K
Other non operating income
1.18K
1.81K
1.63K
3.28K
EBT including unusual items
-649.69K
-537.92K
-578.48K
-618.47K
EBT excluding unusual items
-649.69K
-537.92K
-578.48K
-618.47K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-649.69K
-537.92K
-578.48K
-618.47K
Net profit margin
-92.79%
-52.12%
-52.74%
-47.50%
Earnings per share
-
-
-0.01
-
Interest and investment income
1.15K
409.00
-
-
Interest expense
-
-
-771.00
-175.28K
Net interest expenses
1.15K
409.00
-771.00
-175.28K
Depreciation and amortization charges
-
-
-
-
EBITDA
-628.97K
-516.99K
-555.43K
-424.21K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more